Our Latest News

Open letters 10/05/2012

Urgent Complaint on the Human Rights of Immigrants and Sex Workers in Greece

Below a complaint to Mr. Grover, UN Special Rapporteur on the Right to the Highest Attainable Standard of Health, from the Positive Voice, the European AIDS Treatment Group, and Human Rights Watch on two issues of urgent and serious concern in Greece: the administrative detention and compulsory medical testing of immigrants and asylum seekers based on health status and the arrest, criminal prosecution and compulsory HIV testing of sex workers.

Vacancies 19/04/2012

Training and Communications Coordinator

EATG is now looking for a Training & Communications Coordinator (TCC) to coordinate training projects where EATG is lead or partner organisation and the work on external communication (such as website, newsletters, press releases, etc.).

Projects 19/04/2012

Network of Low HIV Prevalence Countries in Central and South East Europe

NeLP (The Network of Low HIV Prevalence Countries in Central and Southeast Europe) received financial support from TACSO (Technical Assistance for Civil Society Organizations) for an application to the open call: Support to Regional CSO Networks in the IPA countries. The granted amount will be used to organize the NeLP III strategic meeting aimed at development of the strategic and action plan to ensure effective ongoing HIV advocacy in the region.

Positions 28/03/2012

Position Paper: Research and Development for Poverty-Related and Neglected Diseases

During the last decade, higher investments in research addressing the health needs of poor and marginalized populations have resulted in scientific advances that have provided unprecedented opportunities to develop effective and affordable tools to tackle the world’s most pressing global health problems.

Statements 22/03/2012

Accelerating progress in Europe to Universal Access to HIV Treatment during a time of financial crisis

As representatives of HIV civil society from across the European region, meeting together on 6 December 2011 at the HIV/AIDS Civil Society Forum, we call on all governments, on the European Commission and on all those with relevant responsibilities in Europe to live up to their commitments in the response to HIV.

EATG Newsletters 19/03/2012

Newsletter March, Issue I, 2012

A great part of this newsletter of 2012 is dedicated to inform you about our goals and objectives, as well as our plans for this year. This edition also covers a wide range of topics related to our policy, research and training work.

Open letters 15/03/2012

The HIV epidemic in Eastern Europe is out of control and entering into care late is fuelling an HIV/TB epidemic

Copenhagen/Brussels - The HIV epidemic is rapidly expanding in Eastern Europe. In Russia, Ukraine and Belarus the number of people living with HIV has almost tripled since 2000 and mortality is increasing.

Open letters 10/02/2012

Letter to Michel Kazatchkine, Executive Director of the Global Fund to Fight Aids, Tuberculosis, and Malaria

A letter has been sent to Michel Kazatchkine, Executive Director of the Global Fund to Fight Aids, Tuberculosis, and Malaria, to thank him for his personal contribution to the positive impact that programs funded by the Global Fund have had on millions of lives in the region of Europe and Central Asia.

Global HIV News

Prevention 16/05/2012

HIV prevention measures must include behavioral strategies to work, says APA

Truvada alone not sufficient, given adherence and other challenges.

World Policy 16/05/2012

Dangerous doses

Fighting fraud in the global medicine supply chain.

Prevention 16/05/2012

GeoVax Labs reports 2012 first quarter financial results

Data from Phase 2a preventive HIV vaccine trial expected in late 2012; Phase 1/2 therapeutic vaccine trial patient enrollment advancing; Unprecedented preclinical results with adjuvanted vaccine – new human trial opened; Comments on Gilead Science’s Truvada® prevention submission.

Treatment 16/05/2012

HIV linked to risk of sudden cardiac death

People with HIV have more than four times the risk of sudden cardiac death than the general population.

Treatment 16/05/2012

Cancer and higher mortality in HIV+ vs general population in Italy

HIV-positive people in Italy continue to have a 6 times higher risk of death than the general population. And HIV-positive people with cancer have a 15 times higher risk.

Tuberculosis & Malaria 16/05/2012

ART reduces TB risk, even in high-income countries

However, the benefit is not seen in patients who start ART at very low CD4-cell counts.

Hepatitis 16/05/2012

Achillion: ACH-3102 receives Fast Track designation from the FDA for the treatment of chronic hepatitis C

ACH-3102 is a pan-genotypic second-generation NS5A inhibitor against HCV that is currently being evaluated in a Phase 1 clinical trial.

Print